|
DGAP-News: SHS Gesellschaft für Beteiligungsmanagement mbH
/ Key word(s): Disposal
PRESS RELEASE Healthcare investor SHS sells stake in Crystal Laser Systems GmbH, a leading manufacturer of deep-UV laser systems for the healthcare, biotech and semiconductor industries
Tübingen, 11 March 2021 SHS Gesellschaft für Beteiligungsmanagement mbH is selling its stake in Berlin-based laser specialist Crystal Laser Systems GmbH (CryLaS) to mid-market investor Silver Investment Partners (SIP). From the beginning, the Tübingen-based healthcare investor SHS has supported CryLaS on its way to becoming a profitable and renowned specialist provider of deep UV laser systems. High-precision laser systems, such as those manufactured by Berlin-based Crystal Laser Systems GmbH, are needed in industries that require extreme accuracy and speed in analysis or processing. The founders of CryLaS recognized this market potential for high-precision laser technology early on and, with the support of SHS, pushed ahead with CryLaS' corporate and product development. The company, now with around 50 employees, has established itself as a specialist for lasers with high beam quality and reliability. Customers include leading suppliers of wafer inspection systems, mass and Raman spectroscopy, and cell analytics. "When we became involved in CryLaS, we were convinced that Dr. Spanner and his team would be able to play a leading role in laser technology with their innovative strength and will," says Dr. Bernhard Schirmers, who has been leading the SHS involvement. "CryLaS has succeeded in transforming high technology into globally competitive products. We supported this process with capital and know-how and are handing over a profitable company with further potential to an experienced investor." CryLaS and SIP aim to expand technology leadership Together, CryLaS and investor Silver Investment Partners plan to expand the development of new products and services as well as custom applications. CryLaS is convinced that with SIP it will be able to strengthen its internationally strong competitive position. In addition to products with extensive patent protection and an international customer base with renowned names, CryLaS' highly motivated research team is one of the pillars of its success. "Our goal as an investor is to further expand CryLaS' strong market position together with the entire team. SIP sees itself as an entrepreneurial partner. With CryLaS, we plan to enter new markets, expand production capacities, and develop new, technologically unique products," enthuses Philipp Amereller, managing partner of Silver Investment Partners. "CryLaS owes its current strong position also to the far-sighted and consistent commitment of SHS, which has opened the doors to this industry for us with its expertise in the healthcare sector," says CryLaS CEO Dr. Helmut Spanner, who is looking forward to the next steps alongside Silver Investment Partners. About SHS Gesellschaft für Beteiligungsmanagement mbH SHS Gesellschaft für Beteiligungsmanagement is based in Tuebingen, Germany, and invests in medical technology and life science companies with a focus on expansion financing, changes in shareholder structures and successor situations. SHS holds minority as well as majority interests. The company was founded in 1993 and has since gained extensive experience as an industry investor which supports the growth of its portfolio companies through a network of partnerships regarding the introduction of new products, regulatory issues or entering new markets. The SHS fund's European based investors include pension funds, strategic investors, funds of funds, family offices, entrepreneurs and the SHS management team. The AIFM-registered company invests up to €30 million in equity capital and volumes exceeding this amount are implemented with a network of co-investors. SHS is currently investing from its fifth fund which received capital commitments of more than €130 million. Are you interested in receiving regular updates about SHS? Subscribe to our newsletter and follow us on LinkedIn PR contact: Norbert Kraas About CryLaS CryLaS was founded in 1990 and has since been headquartered in Berlin, Germany. The company manufactures continuous wave deep UV lasers for various high-tech industries, including in particular the semiconductor industry, medical technology and forensics. CryLaS' products include pulse lasers and CW lasers, which are suitable for high-tech applications with their short wavelengths and low, targeted powers. Over the years, CryLaS has developed several market niches and is now the world leader in laser systems for wafer inspection. About Silver Investment Partners Silver Investment Partners is an independent investor in equity financing for medium-sized companies in Germany, Austria and Switzerland. As an entrepreneurial, experienced and reliable partner, Silver Investment Partners engages in majority and minority investments in companies with revenues between 5 and 100 million Euros, with a focus on companies with revenues between 10 and 50 million Euros.
11.03.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
1174867 11.03.2021
